The relationship between clinically assessed and free-living walking is unclear. Cadence (steps/ min) can be measured accurately under both conditions using modern technologies, thus providing a common measurement metric. Therefore, the purpose of this study was to compare clinical and free-living cadence in older adults. Methods: 15 community-dwelling older adults (7 men, 8 women; 61-81 years) completed GAITRite-determined normal and dual-task walks and wore objective monitors for 1 week. Descriptive data included gait speed (cm/sec), steps/day, as well as cadence. Nonparametric tests evaluated differences between normal and dual-task walks and between accelerometer-and pedometer-determined steps/day. Free-living time detected above clinically determined cadence was calculated. Results: Participants crossed the GAITRite at 125.56 ± 15.51 cm/sec (men) and 107.93 ± 9.41 steps/min (women) during their normal walk and at 112.59 ± 17.90 cm/sec and 103.10 ± 1.30 steps/min during their dual-task walk (differences between walks P < .05). Overall, they averaged 7159 ± 2480 (accelerometer) and 7813 ± 2919 steps/day (pedometer; difference NS). On average, < 10 min/day was spent above clinically determined cadences. Conclusions: High-functioning, community-dwelling older adults are capable of walking at relatively high cadences (ie, > 100 steps/min). However, the same behavior appears to be uncommon in daily life, even for a minute.
Gait speed is a simple, safe, and easy clinical and laboratory assessment used to identify older adults at risk for a number of adverse outcomes, including disability, cognitive decline, falls, institutionalization, and survival. [1] [2] [3] [4] Beyond the clinic and laboratory, regular walkers show less decline in habitual gait speed than those who report no volitional walking. 5, 6 Further, selfreported walking speed in the free-living context has been inversely related to mortality from all causes, coronary heart disease, and total cancers. 7 However, the relationship between clinically assessed gait speed and free-living walking speed is unclear, in part because it is difficult to get a true estimate of speed expressed naturally and in real-time under free-living conditions, at least beyond that which can be obtained from covert observation conducted in specific settings. [8] [9] [10] To be very clear, the scientific literature is silent in regards to free-living time spent at clinically assessed gait speeds.
Cadence (steps/min) is one of the spatial-temporal parameters of gait/walking speed (the other being stride, or more correctly, step length). Cadence increases with walking speed and is the primary strategy implemented up to individually preferred walking speeds. 11 Cadence and step length are equal contributors to increases in speed beyond preferred walking speed to faster walking speeds, 11 and although changes in step length contribute relatively more to accelerating running speeds, cadence can still increase to some extent. 12 Cadence can also be measured accurately under both clinical and free-living conditions using modern technologies, thus providing a common metric by which the two can be compared. However, we know of no study which has investigated this methodological opportunity. Thus, the purpose of this preliminary study was to compare clinical and free-living measures of cadence in an older adult sample. Specifically, we sought to answer how common it is for older adults to naturally ambulate at the cadence that a clinical assessment indicates they are capable of performing.
Methods

Participants
Participants (7 men, 8 women; 61-81 years of age) were recruited for this preliminary cross-sectional study from rosters of potential research volunteers maintained for ongoing research conducted by the Institute for Dementia 
Short Physical Performance Battery (SPPB)
The SPPB is a brief series of tests used to assess functional ability. It combines the results obtained from progressively challenging but simple balance tasks, a timed short distance walk, and timed repeated chair stands into an aggregate score that can range from 0 (indicating inability to perform any component) to 12 (unlimited in functional ability). 13 
Clinically Assessed Gait
Gait variables (speed, cadence) were assessed using a 20-foot GAITRite computerized walkway system (CIR Systems, Havertown, PA, USA) under 2 conditions: 1) normal walking and 2) dual-task walking (participants were asked to spell a 5-letter word backward as they crossed the walkway threshold). Dual-task walking is a common testing paradigm used to assess the impact of a combined cognitive and motor challenge. 14 Standard instructions were given to all participants. Participants were given a 2-m acceleration and deceleration distance on either end of the walkway and 2 practice trials before performing 3 crossings under each condition, with rest provided as needed. Outputs were averaged for the 3 crossings.
Free-Living Assessment
Participants volunteered to wear a GT3X+ (ActiGraph, Pensacola, FL, USA) accelerometer (initialized to record data in 80 Hz using the ActiLife5 software version 5.5) and a New Lifestyles NL-1000 pedometer (Lee's Summit, MO, USA) at the waist until returning the equipment 7 days later. They were asked to wear the accelerometer for 24 hours a day and wear the pedometer during waking hours. Otherwise, both instruments were only to be removed for showering/bathing or other water activities. Participants were also asked to log the times that they attached and removed the pedometer, as well as daily steps taken as recorded by the pedometer. In addition, step data retained in the pedometer's 7-day memory function were recorded upon return of the instruments to the study center. We did not collect any self-reported physical activity data.
Data Treatment
Height and weight were used to compute body mass index (BMI; kg/m 2 ). For this analysis we present the SPPB aggregate score as well as gait speed (cm/sec) derived from dividing the short distance walk (4 m) by the time taken to complete it. Cadence and speed were averaged for the condition-specific GAITrite walkway crossings. Accelerometer data were downloaded using the ActiLife5 software in 60-second epochs (time recording intervals). Using the standard manufacturer-provided step filter, data were then treated using standard decision rules imbedded in a National Cancer Institute (NCI)-supplied SAS macro (http://appliedresearch.cancer.gov/tools/ nhanes_pam/). Specifically, we defined accelerometer nonwear time as ≥ 60 minutes of consecutive zeros and a valid day of data recording at least 10/24 hours of wear time. These are the same standard decision rules that have been used for National Health and Nutrition Examination (NHANES) accelerometer data analysis and the rationale for their use has been provided elsewhere. 15, 16 Similar to other previous analyses of the NHANES accelerometer data, 17 we computed mean min/day (averaged over valid days) accumulated during wearing time in established cadence bands: at 0 cadence (defined as nonmovement during wearing time), 1-19 (incidental movement), 20-39 (sporadic movement), 40-59 (purposeful steps), 60-79 (slow walking), 80-99 (medium walking), 100-119 (brisk walking), and 120+ steps/min (including all faster ambulation). Minute-by-minute step data were also rank ordered within each valid data to compute peak 30-minute cadence (mean steps/min detected for the 30 highest, not necessarily consecutive minutes in a day), and peak 1-minute cadence (the highest single minute record of steps/min on a day). 18 These were then averaged across valid days for each participant and presented as the sample mean. Peak cadence indicators have been used previously to characterize ambulatory activity patterns of older adult samples living with and without chronic disease. 19 Mean time (min/day) above individual results for clinical assessment of normal and dual-task walking cadences were also calculated.
Pedometer step data retrieved from the instrument's memory were the default source of these data. Where this was not available (eg, when instruments were returned at a time beyond the capability of instrument memory stores), then the participant logged values were taken. In a separate sample of older adults we determined that participant and pedometer memory-recorded steps/ day differed by only 4.4 (13.9) steps/day (unpublished data based on 12 similar older adult also recruited from IDRP, following the same instrument wearing protocol as described herein, and providing a total of 62 days of the 2 types of recorded data). Pedometer step data were averaged across days.
Statistical Analyses
Descriptive data were presented as means (SD) or frequencies as appropriate. In this relatively small sample data were skewed, so nonparametric inferential tests were conducted. Differences in distributions of variables by gender were evaluated using the Mann-Whitney U test for 2 independent samples. Differences between variables from related samples (eg, different tests of gait speed within individuals) were assessed using the Wilcoxon Signed Rank test. Analyses were conducted using SPSS 19 statistical software (IBM Corp, Somers, NY).
Results
Participants wore the accelerometers for an average of 5.9 (0.35) days (range 5-6 days) and for 17.14 (2.16) hours daily (range 14.43-21.32 hours), which is higher than average wear time (14.2 hours) reported for a nationally representative sample. 16 Participants reported wearing the pedometer for 14.7(1.41) hours/day.
Descriptive characteristics for the sample are presented in Table 1 . Participants were, on average, overweight, and SPPB scores confirm that this was a highfunctioning sample of older adults. Gait speeds (obtained from either SPPB short distance walk or from GAITrite walkway) were also faster than 80 cm/sec which has been put forward as a cut point indicative of risk of adverse outcomes. 2 Apparent differences in gait speed between the 2 clinical tests of normal walking speed were not statistically different. However, differences in speed between the GAITrite-assessed normal walk and the dual-task walk were statistically different (P < .003; Table 1 ). Differences in cadence between normal and dual walk were only statistically different for women (P < .05; Table 1 ). Differences between genders were not statistically significant for any variable. However, based on mean steps/day values (either accelerometer or pedometer-based), men were classified (on average) as somewhat active and women were classified as low active according to an established graduated step index. 20 For both men and women, the greatest amounts of monitored time were spent in nonmovement and incidental movement with incrementally less time spent at each successively higher cadence band (Figure 1 ). There were no significant differences between accelerometer and pedometer-determined steps/day (Table 1) . With the exception of the men's peak 1-minute cadence, all other peak cadence indicators were lower than the clinically assessed normal cadence. On average, < 10 min/day were spent above individual normal and dual-task cadence values obtained from the GAITRite assessment.
Discussion
This preliminary comparison of clinical and free-living measures of cadence clearly demonstrated that, although community-dwelling and high-functioning older adults are capable of, and preferentially select, walking at relatively higher cadences under testing conditions, time spent at such cadences is rare is the free-living context. In a study of 82 community-dwelling older men, Morie et al 21 showed that, compared with those with lower accelerometer-determined physical activity levels (based on a median split), those with higher levels also had higher SPPB scores and a 35 cm/sec faster clinically assessed walking speed. However, Zalewski et al 22 showed no relationship (Pearson correlations) between physical performance measures that included gait speed assessments and accelerometer-determined physical activity in 59 older adults who were residents of a continuing care retirement community. In the current study we attempted to push past analysis of general relationships and compare clinically assessed gait and free-living ambulation using the same measurement metric: cadence. Such an approach helped us to clearly identify the differences in the performance-based assessment of cadence vs. its natural behavioral expression in daily life. Despite individual variation, research [23] [24] [25] [26] [27] has consistently demonstrated that a cadence of 100 steps/min can serve as a reasonable indicator of absolutely defined moderate intensity defined as 3 METs (metabolic equivalents; 1 MET= 3.5 ml of O 2 consumed per kg/min or 1 kcal/kg/min) in adults. The clinical gait tests administered herein confirm that this cadence is well within that which is attainable by older adults similar to those studied, even under a distracted condition. However, this sample averaged only ≅ 8 min/day at cadences ≥ 100 steps/min (Figure 1) , and peak 30-minute cadences only reached ≅ 78 and ≅ 68 steps/day for men and women, respectively. Although the peak 1-minute cadence value was slightly greater than clinically determined normal cadence in men, the other peak-cadence indicators also demonstrate that habitual free-living ambulation is typically much lower. Calibration to individual results of the clinical gait test did not improve free-living findings.
A recent analysis of the National Health and Nutrition Examination Survey (NHANES) accelerometer data has also examined time accumulated in the same cadence bands as used in the current study. 17 Our older adult sample accumulated ≅ 9.2 hours/day at 0 cadence compared with ≅ 4.8 hours/day reported for the nationally representative sample. At least one explanation for the dramatic differences in estimates is that we used a 24-hour accelerometer wear time protocol whereas the NHANES used a waking hours protocol. At least some of the discrepancy is due to detected sleeping time. Reduced wearing time (due to premature removal or delayed attachment of the device) is also known to have its greatest impact on estimates of inactivity/sedentary behavior. 15, 28 In designing our study we decided that using a 24-hour protocol would provide us with the most inclusive estimates. That being said, we used a waking hours protocol for pedometer wear, and there were no significant differences in steps/day detected by either the accelerometer or the pedometer, suggesting that the less expensive pedometer worn only for waking hours provided a comparable estimate of detected movement. Stated another way, there was little movement detected by the accelerometer when the pedometer was not worn.
As mentioned above, Gardner et al 19 have reported peak cadence indicators for older adult samples living with and without chronic disease. They used an instrument that detects strides (from footfall of one foot to footfall on the same foot) instead of steps (from footfall of one foot to footfall of the other foot), so their results are doubled here to compare directly to cadence presented as steps/min. They reported a peak 30-minute cadence of 62 steps/min and a peak 1-minute cadence of 100 steps/ min for their ostensibly healthy older adult subsample. Our comparable values were 73 and 101 steps/min. The relatively higher peak 30-minute cadence observed in our sample despite a similar peak 1-minute cadence would suggest that our sample did not necessarily walk at a faster peak cadence but was somewhat more regularly active by comparison.
This was a cross-sectional study focused on a limited sample size of high-functioning, community-dwelling older adults and results are therefore best described as preliminary. Even though standard instructions were given for the gait test and participants were given practice, there remains a possibility for observation bias. However, the values we obtained for this assessment are congruent with published gender-and age-specific normative values. 29 Cadence is obviously an estimate of ambulatory activity and not all human movement may be captured by this simple metric. However, given the accepted importance of gait speed as an indicator of risk of adverse events in older adults, 2 it is prudent that we also capture similar estimates in free-living. Since real-time free-living gait speed is illusive with current technologies, cadence presents a unique opportunity to study the same metric under 2 distinct conditions. While our data indicates that free-living measures of cadence may be useful in measuring changes in physical activity, a key directive for future studies is to establish normative data for different ages and morbidities. In addition, the relative importance of free-living versus clinical assessments of cadence in predicting adverse outcomes in older adults was not evaluated in this preliminary study yet remains a particularly important area for future research. Finally, we did not collect self-reported physical activity data so we do not know whether these participants actually characterized themselves as regular walkers. However, an intriguing tangential question worthy of independent investigation is: what cadence are people really walking at if they say they are walking in the free-living context?
In summary, cadence can be detected using modern technologies under both clinical and free-living conditions. The results suggest that high-functioning, community-dwelling older adults are capable of walking at cadences higher than that associated with absolutely defined moderate intensity, even when distracted. However, the same free-living behavior appears to be uncommon, possibly because there may be few occasions to engage in such behavior in daily life, even for a minute. We can only presume that such behavior is an even rarer phenomenon in lower-functioning older adults and those living in more institutional settings. This is a concern as the benefits of regular physical activity for all older adults are robust and well known. Since clinically assessed gait speed is an undisputed important clinical indicator of several adverse outcomes in aging, and since physical activity (and specifically walking behavior) is predictive of changes in gait speed, further research to understand the relationship between clinical and free-living measures of cadence is warranted. Specifically, characterizing where, when, why, how, and with whom older adults engage in higher cadence walking may offer a unique opportunity to understand barriers and facilitators to healthy, active aging. Such information can inform specific intervention and rehabilitation strategies based not only on "how much," but also "how fast."
